BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31247015)

  • 41. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
    Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
    J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
    Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
    Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
    Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.
    Maeda H; Matsumura A; Kawabata T; Suito T; Kawashima O; Watanabe T; Okabayashi K; Kubota I;
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):357-61. PubMed ID: 21737295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer.
    Fernandes OJ; Almgren SO; Thaning L; Filbey D; Helsing M; Karlsson M; Magnusson A; Souza D
    Acta Oncol; 2003; 42(4):338-41. PubMed ID: 12899506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Factors predictive of survival after lobectomy for non-small cell lung cancer in Iceland during 1999-2008].
    Oskarsdóttir GN; Skúladóttir R; Isaksson HJ; Jónsson S; Thorsteinsson H; Gudbjartsson T
    Laeknabladid; 2010 Apr; 96(4):251-7. PubMed ID: 20339164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
    Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
    J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.
    Alexander M; Wolfe R; Ball D; Conron M; Stirling RG; Solomon B; MacManus M; Officer A; Karnam S; Burbury K; Evans SM
    Br J Cancer; 2017 Aug; 117(5):744-751. PubMed ID: 28728168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
    Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients.
    Boros A; Lacroix L; Lacas B; Adam J; Pignon JP; Caramella C; Planchard D; de Montpreville V; Deutsch E; Levy A; Besse B; Le Pechoux C
    Oncotarget; 2017 Apr; 8(15):25189-25199. PubMed ID: 28445990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.
    Belani CP; Chakraborty BC; Modi RI; Khamar BM
    Ann Oncol; 2017 Feb; 28(2):298-304. PubMed ID: 27831503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
    Chabowski M; Orłowski TM; Rabczenko D
    Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of non-small cell lung cancer 3 cm or less in diameter.
    Tateishi M; Fukuyama Y; Hamatake M; Kohdono S; Mitsudomi T; Ishida T; Sugimachi K
    J Surg Oncol; 1995 Aug; 59(4):251-4. PubMed ID: 7630173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.